CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
ASSETS
Current assets:
Cash and Cash Equivalents, at Carrying Value $117.6m $163.8m $195.4m $238.0m $228.4m $241.2m $233.9m $276.8m $194.6m $213.8m
Prepaid Expense and Other Assets, Current $45.0m $81.3m $48.8m $56.0m $72.6m $97.3m $107.6m $83.4m $105.8m $129.2m
Short-term Investments $3.8m $28.5m $885k $941k $1.0m $1.1m
Inventory, Net $95.8m $115.0m $127.9m $160.7m $185.7m $199.1m $255.8m $380.3m $278.5m $299.1m
Assets, Current $656.8m $826.6m $897.8m $1.0b $1.2b $1.3b $1.4b $1.6b $1.4b $1.4b
Property, Plant and Equipment, Net $755.8m $782.0m $932.9m $1.0b $1.1b $1.3b $1.5b $1.6b $1.6b $1.7b
Goodwill $787.5m $804.9m $1.2b $1.5b $1.8b $2.7b $2.8b $3.1b $2.8b $2.8b
Operating Lease, Right-of-Use Asset $140.1m $178.2m $292.9m $391.8m $394.0m $412.5m $361.4m
Other Assets, Noncurrent $88.4m $124.0m $143.8m $212.6m $352.6m $352.9m $148.3m $309.4m $278.2m $293.2m
Additional Financial Items
Accounts Receivable, after Allowance for Credit Loss, Current $364.1m $430.0m $472.2m $514.0m $617.7m $642.9m $752.4m $780.4m $720.9m $708.9m
Accrued Liabilities, Current $84.5m $89.8m $106.9m $139.1m $149.8m $228.8m $219.8m $227.8m $232.0m $270.1m
Assets $2.7b $2.9b $3.9b $4.7b $5.5b $7.0b $7.6b $8.2b $7.5b $7.1b
LIABILITIES AND EQUITY
Current liabilities:
Operating Lease, Liability, Current $20.4m $24.7m $33.3m $46.5m $54.9m $54.2m $57.7m
Accounts Payable, Current $68.5m $77.8m $66.2m $111.5m $122.5m $198.1m $205.9m $168.9m $140.3m $148.8m
Operating Lease, Liability, Noncurrent $116.3m $155.6m $253.0m $389.7m $419.2m $483.8m $434.0m
Deferred Revenue, Current $127.7m $117.6m $145.1m $171.8m $207.9m $219.7m $264.3m $241.8m $248.3m $210.4m
Long-term Debt, Excluding Current Maturities $1.2b $1.1b $1.6b
Long-term Debt, Current Maturities $24.6m $28.5m $28.2m $35.5m $47.2m $101k $1.3m $3.2m $155k $166k
Liabilities, Current $429.6m $463.5m $558.2m $710.2m $839.8m $1.0b $1.1b $1.1b $994.1m $1.1b
Deferred Income Tax Liabilities, Net $55.7m $89.5m $143.6m $167.3m $217.0m $239.7m $215.6m $191.3m $107.0m $95.2m
Other Liabilities, Noncurrent $159.2m $194.8m $179.1m $182.9m $205.2m $242.9m $174.8m $223.2m $195.2m $138.3m
Deferred Tax Liabilities, Net $27.0m $66.9m $120.3m $122.6m $179.3m $199.5m $174.3m $151.1m $64.8m $27.9m
Liabilities $1.9b $1.9b $2.5b $3.0b $3.3b $4.4b $4.6b $4.5b $4.0b $3.9b
Redeemable Noncontrolling Interest, Equity, Carrying Amount $14.7m $16.6m $18.5m $28.6m $25.5m $53.0m $42.4m $56.7m $41.1m $41.3m
Stockholders’ equity:
Preferred Stock, Value, Issued $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Common Stock, Value, Issued $863k $875k $482k $489k $498k $505k $509k $513k $511k $492k
Retained Earnings (Accumulated Deficit) $165.3m $288.7m $42.1m $280.3m $625.4m $980.8m $1.4b $1.9b $1.8b $1.4b
Accumulated Other Comprehensive Income (Loss), Net of Tax ($253.8m) ($144.7m) ($172.7m) ($178.0m) ($138.9m) ($164.7m) ($262.1m) ($196.4m) ($317.3m) ($171.8m)
Additional Paid in Capital, Common Stock $2.5b $2.6b $1.4b $1.5b $1.6b $1.7b $1.8b $1.9b $2.0b $1.9b
Stockholders' Equity Attributable to Parent $836.8m $1.0b $1.3b $1.6b $2.1b $2.5b $3.0b $3.6b $3.5b $3.2b
Stockholders' Equity Attributable to Noncontrolling Interest $2.4m $2.3m $2.4m $3.2m $3.6m $4.2m $4.8m $5.4m $5.4m $5.3m
Liabilities and Equity $2.7b $2.9b $3.9b $4.7b $5.5b $7.0b $7.6b $8.2b $7.5b $7.1b

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.